| Record ID | marc_loc_2016/BooksAll.2016.part40.utf8:179364301:1322 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part40.utf8:179364301:1322?format=raw |
LEADER: 01322cam a2200397 a 4500
001 2012936109
003 DLC
005 20150210083742.0
008 120326s2012 nyua b 001 0 eng c
010 $a 2012936109
016 7 $a101586715$2DNLM
016 7 $a015821137$2Uk
020 $a9781441959539 (alk. paper)
020 $a144195953X (alk. paper)
020 $a9781441959553 (eBook)
020 $a1441959556 (eBook)
035 $a(OCoLC)ocn801917605
040 $aNLM$beng$cNLM$dUKMGB$dDLC
042 $apcc
050 00 $aRM282.M65$bD48 2012
060 00 $a2012 E-861
060 10 $aQW 575.5.A6
082 00 $a616.07/98$223
245 00 $aDevelopment of antibody-based therapeutics :$btranslational considerations /$cMohammad A. Tabrizi, Gadi G. Bornstein, Scott L. Klakamp, editors.
260 $aNew York :$bSpringer,$cc2012.
300 $axiv, 425 p. :$bill. ;$c24 cm.
504 $aIncludes bibliographical references and index.
650 0 $aMonoclonal antibodies$xTherapeutic use.
650 12 $aAntibodies, Monoclonal$xpharmacology.
650 22 $aAntibodies, Monoclonal$xtherapeutic use.
650 22 $aAntigens$ximmunology.
650 22 $aDrug Discovery.
650 22 $aTranslational Medical Research.
700 1 $aTabrizi, Mohammad A.
700 1 $aBornstein, Gadi G.
700 1 $aKlakamp, Scott L.